Company Overview and News

 
Golden Leaf Holdings Announces New Green Apple Flavor CBD Infused Fruit Chews

2018-10-08 globenewswire
PORTLAND, Ore., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized brands, today announced the introduction of its new CBD-only Green Apple flavor as an extension of its cannabis-infused fruit chews product line. The chews are marketed and sold under the Company’s “Golden” brand and are currently available in Oregon, both at the Company’s Chalice Farms stores and 3rd party dispensaries.
GLH GLDFF

1
MPX to Participate in Panel at 2018 Cannabis World Congress Business Expo

2018-09-25 globenewswire - 1
TORONTO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC: MPXEF) announced that Beth Stavola, Chief Operating Officer of MPX, will be speaking at the ‘Cannabis and the Capital Markets’ panel at the Cannabis World Congress Business Expo (CWCBE) being held on Thursday, September 27, 2018 at the Los Angeles Convention Center in downtown Los Angeles.
MPXEF MTEC GLH BCC MTECU CBICF GLDFF

1
Golden Leaf Holdings’ Subsidiary, Medical Marijuana Group Corp, Acquires Sales License from Health Canada

2018-09-24 globenewswire - 1
TORONTO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized brands, today announced its 100 percent-owned Canadian subsidiary Medical Marijuana Group Corporation (“MMG”), a Licensed Producer in St Thomas, Ontario received its Sales License from Health Canada on Friday September 21, 2018.
GLH GLDFF

3
Golden Leaf: Is This U.S. Cannabis Company Near A Turnaround?

2018-09-21 seekingalpha - 3
The stock is suffering from an overhang resulted from a pre-announced 25% equity issuance used to fund its latest acquisition.
MPXEF GLH GLDFF

2
Liberty Health Sciences: Surviving And Thriving After Aphria

2018-09-19 seekingalpha - 2
In May, we concluded that Liberty Health is an attractive way to play the U.S. cannabis market, but the company's near-term outlook is clouded by Aphria overhang.
ISOLF MPXEF LHSIF ISOLD APHQF GLH GLDFF

1
Golden Leaf Holdings Refiles Amended and Restated MD&A

2018-09-07 globenewswire - 1
TORONTO, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized brands, today announced that it has supplemented the disclosure in its Management Discussion and Analysis for the period ended March 31, 2018 and has filed an amended and restated version of such MD&A (the “Revised MD&A”).
GLH GLDFF

 
UPDATE -- Golden Leaf Holdings Adds Chief Marketing and Sales Officer to Business Development Team

2018-09-07 globenewswire
TORONTO, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized brands, today announced that it has named Jeff Yapp as its new Chief Marketing and Sales Officer. In his new role, Mr. Yapp will be responsible for setting Golden Leaf’s global retail and franchising strategy, and overseeing the Company’s wholesale revenue, marketing and public relations initiatives.
GLH GLDFF

1
Golden Leaf Hldgs Ltd (GLDFF) CEO William Simpson on Q2 2018 Results - Earnings Call Transcript

2018-08-29 seekingalpha - 1
Golden Leaf Hldgs Ltd (OTCQB:GLDFF) Q2 2018 Earnings Conference Call August 29, 2018 4:30 PM ET
GLH GLDFF

 
Golden Leaf Reports Fiscal Second Quarter 2018 Results

2018-08-29 globenewswire
TORONTO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized brands, today announced financial results for the fiscal second quarter ended June 30, 2018, and a general business update.
GLH GLDFF

 
Golden Leaf Holdings to Hold Conference Call to Review Second Quarter 2018 Results

2018-08-20 globenewswire
PORTLAND, Ore., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized brands, today announced that it will report its financial results for the quarter ended June 30, 2018 on Wednesday, August 29, 2018, after market-close. Golden Leaf’s management, led by William Simpson, Chief Executive Officer, will also hold a conference call to review the results at 4:30 PM ET on Wednesday, August 29, 2018.
GLH GLDFF

 
Golden Leaf To Acquire Tahoe – A Leading Nevada Producer

2018-08-13 globenewswire
PORTLAND, Ore., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE:GLH) (OTCQB:GLDFF) (“Golden Leaf” or the “Company”), a cannabis company with cultivation, production and retail operations built around recognized brands, today announced it has signed a definitive agreement (the “Agreement”) to acquire the assets of Tahoe Hydroponics Company and 11T Corp. (collectively “Tahoe”) (the “Transaction”) on August 10, 2018.
GLH GLDFF

 
Golden Leaf Holdings Management to Attend Upcoming Conferences in U.S. and Canada

2018-08-03 globenewswire
PORTLAND, Ore., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized brands, today announced its upcoming attendance at a number of major cannabis industry and investor events.
GLH GLDFF

 
Golden Leaf Holdings Receives State Licensure Approval For Extraction Facility In Portland

2018-07-25 globenewswire
PORTLAND, Ore., July 25, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized brands, today announced it received from the Oregon Liquor Control Commission state licensure to operate its extraction facility in the city of Portland, Oregon, effective July 19, 2018.
GLH GLDFF

1
Canada, set to legalize marijuana, becomes go-to place for cannabis companies

2018-07-25 newsinfo.inquirer.net - 1
FILE – In this June 2, 2016 file photo, William Simpson, founder of Chalice Farms, holds a display of his company’s cannabis-infused truffles, chocolates and gummy candies at the company headquarters in Portland, Ore. In recent months, prominent U.S. pot companies including MedMen, Liberty Health Care and Chalice Farms have listed on the Canadian Securities Exchange, raising capital and drawing attention from wealthy investors in Asia, Europe and Australia who want to make a play in the cannabis industry but are spooked by the U.
GLH TLRY GLDFF

2
For US pot companies, Canada is the land of opportunity

2018-07-25 nzherald.co.nz - 2
PORTLAND, Ore. (AP) — Green Thumb Industries had a business plan, expertise and plenty of ambition to grow its marijuana business. What the Chicago-based company didn't have was access to enough capital to make it all happen.
GLH TLRY GLDFF

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to CNSX:GLH / Golden Leaf Holdings Ltd on message board site Silicon Investor.

Golden Leaf GLH or GLDFf Golden Leaf GLH or GLDFf Golden Leaf GLH or GLDFf Gaming Lottery Corp. Whats your opinion? Gaming Lottery Corp. Whats your opinion? Gaming Lottery Corp. Whats your opinion?